Mike received his Ph.D. in Biology from The Johns Hopkins University and later obtained an MBA from Frostburg State University. He began his biotech industry career in 1989 with one of the founding companies in gene therapy, Genetic Therapy Inc.
As Chief Operating Officer, Mike brings over 30 years of experience in the development and manufacturing of biologics. He has acquired an in-depth understanding of the CMC related issues important for biologics product development and has contributed to numerous IND’s, enabling the clinical evaluation of products ranging from retrovirus, adenovirus, monoclonal antibodies and lentiviral vectors. During his career, Mike has held leadership roles responsible for a wide range of functions, including process development, manufacturing, CMO management, materials management, inventory control, warehouse operations and logistics. In addition, Mike has participated in several capital projects for manufacturing facility design, build and commissioning.
Mike’s recent experience includes five years specializing in Lentiviral vector scale up and manufacturing technology. As Director of Manufacturing at Lentigen Technology Inc. (a Miltenyi company) he led the implementation of a state-of-the-art platform process for lentivirus production and oversaw the successful completion of hundreds of GMP batches of lentiviral vector destined for human clinical trials.
Partner With Us
Talk to our team today to learn more about our Lentiviral vector manufacturing solutions. If you are an academic organization, ask for our academic pricing.